SecBot SecBot

ACON

Aclarion, Inc.
Nasdaq· Services-Medical Laboratories· Inc. DE· CIK 0001635077 Healthcare & Medical Devices
$1.93 −0.00 (−0.26%)
Oct 23 4:00 PM ET · prev $1.93
Market cap
$5.6M
Nano cap
Median target
🔒 Subscribers only
1 year
−74.4%
from $7.55 · Oct 24
30 days
−26.6%
from $2.63
52-week range
$1.85–8.17
−76% from high · low Oct 16
Avg volume 20D
25.7K
Sep 29 spike 79.6K
Short interest
48.9K
≈1.7% of shares · −35.6%
Days to cover
1.0
at average volume
Insider net
+$176.6K
7 buyers · 0 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
3
analyzed by SecBot
SecBot read BULLISH 2 reports · 90 days
Balance 0 bearish · 2 bullish oldest → newest, height = score
Avg score ·High conf. 2/2
Strongest BULLISH Six Aclarion insiders, including the CEO and CFO, made open-market purchases totaling $126K over a 5-day…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    7 insiders bought $176.6K at an average $2.60. No open-market sales. Price is 26% below their cost.

  • InstitutionsMIXED

    Q2 2026: 1 added (0 new), 3 trimmed or exited.

  • Short sellersCOVERING

    Short interest −35.6% to 48.9K shares. 1.0 days to cover, ≈1.7% of shares.

  • TrendDOWNTREND

    19% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
GEODE CAPITAL MANAGEMENT, LLCTRIM12,128$34.9K
OSAIC HOLDINGS, INC.NEAR_EXIT5,000$14.4K
UBS Group AGNEAR_EXIT1,968$5.7K
Clear Street Group Inc.DOUBLED103$297.00
CAPTRUST FINANCIAL ADVISORSADD14,559$47.6K
UBS Group AGDOUBLED9,647$31.5K
UBS Group AGDOUBLED1,729$13.0K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action May 2026

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access
Recent actions
DateFirmActionRating
May 29, 2026Ascendiant Capital
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
$176.6K
bought · 7 insiders
$0
sold · 0 insiders
−25.8%
vs their $2.60 cost
DateInsiderTypeValue
Aug 17, 2026
Williams Amanda M
Director
BUY$16.0K
Aug 14, 2026
Gould Gregory A
CFO
BUY$24.5K
Aug 13, 2026
Bond Ryan
Director
BUY$50.1K
Aug 13, 2026
Wesemann William
Director
BUY$5.0K
Aug 13, 2026
Ness Brent
Chief Executive Officer
BUY$12.1K
Aug 13, 2026
Neal David K
Director
BUY$18.0K
Jun 11, 2026
Thramann Jeffrey John
Executive Chairman
AWARD100,000 sh
Jun 11, 2026
Sequira Amanda Mae
Director
AWARD20,000 sh

Earnings setup

Estimates

Revision history: 🔒 Fresh data — subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data — subscribers only
Next Q🔒 Fresh data — subscribers only
Current FY🔒 Fresh data — subscribers only
Next FY🔒 Fresh data — subscribers only

Short side

FINRA· Sep 30, 2026
48,934
shares short
-35.6%
vs prior settlement
1.0
days to cover
≈1.7%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 19, 2026 SEC
Six Aclarion insiders, including the CEO and CFO, made open-market purchases totaling $126K over a 5-day window…
CLUSTER — Impact 7/10
Aug 18, 2026 SEC
Five Aclarion insiders, including the CEO and CFO, made open-market purchases totaling $110K over a two-day window…
CLUSTER — Impact 6/10
Aug 17, 2026 Insider
Williams Amanda M bought 5,857 shares
Director @ $2.73 ($16.0K)
Aug 14, 2026 Insider
Gould Gregory A bought 10,000 shares
CFO @ $2.45 ($24.5K)
Aug 13, 2026 Insider
Bond Ryan bought 21,122 shares
Director @ $2.37 ($50.1K)
Aug 12, 2026 Other
Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Spectroscopy (MRS) Scan Process
Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Sp
Jun 30, 2026 Inst.
GEODE CAPITAL MANAGEMENT, LLC — TRIM
12,128 shares ($34.9K)
Jun 30, 2026 Inst.
OSAIC HOLDINGS, INC. — NEAR_EXIT
5,000 shares ($14.4K)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Aug 12, 2026
Press release
Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Spectroscopy (MRS) Scan Process
Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Spectroscopy (MRS) Scan Process
Jul 7, 2026
Press release
Aclarion Announces Texas Spine Care Center as New CLARITY Site
Aclarion Announces Texas Spine Care Center as New CLARITY Site
Jun 10, 2026
Press release
Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub
Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub
Jun 9, 2026
Contract
Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform
Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform
Jun 8, 2026
Activist
Aclarion Rejects Echo Lake Capital’s Unsolicited Acquisition Proposal
Aclarion Rejects Echo Lake Capital’s Unsolicited Acquisition Proposal

SecBot reports

3 filings · 7 press releases · 3 bullish · 0 bearish
All ACON filing & press-release reports (10)